Anest. intenziv. Med. 2022;33(3-4):161-163 | DOI: 10.36290/aim.2022.024

Rocuronium­‑induced anaphylactic shock in pregnancy successfully treated with sugammadexCase Report

Musilová T.1, 3, Seidlová D.2, 3, Štourač P.1, 3, Pešková K.2, 3, Řeháčková E.2, 3
1 Klinika dětské anesteziologie a resuscitace, Fakultní nemocnice, Brno
2 II. anesteziologicko­‑resuscitační oddělení, Fakultní nemocnice, Brno
3 Lékařská fakulta Masarykovy univerzity, Brno

Muscle relaxants are the most common cause of allergic reactions during the perioperative period. This reaction could be potentially life-threatening because of the intravenous route of administration of the drugs used for general anesthesia. We describe a case of rocuronium-induced anaphylactic shock in a 26-years-old woman with suspected extrauterine pregnancy successfully treated with sugammadex.

Keywords: anaphylactic shock, pregnancy, rocuronium, sugammadex.

Received: July 4, 2022; Revised: August 9, 2022; Accepted: August 22, 2022; Published: October 27, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Musilová T, Seidlová D, Štourač P, Pešková K, Řeháčková E. Rocuronium­‑induced anaphylactic shock in pregnancy successfully treated with sugammadex. Anest. intenziv. Med. 2022;33(3-4):161-163. doi: 10.36290/aim.2022.024.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Dewachter P, Mouton­‑Faivre C, Emala CW. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology. 2009 Nov;111(5):1141-50. doi: 10.1097/ALN.0b013e3181bbd443. PMID: 19858877. Go to original source... Go to PubMed...
    2. Takise Y, Kato J, Suhara T, Yamada T, Funakoshi T, Takahashi H, et al. Life­‑threatening rocuronium­‑induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report. JA Clin Rep. 2020 Dec 7;6(1):95. doi: 10.1186/s40981-020-00402-y. PMID: 33289045; PMCID: PMC7721765. Go to original source... Go to PubMed...
    3. Hashimoto M, Sato Boku A, Tachi N, Okumura Y, Kadoi K, Harada J, et al. Two Cases of Rocuronium­‑Induced Anaphylaxis/Anaphylactic Shock Successfully Treated With Sugammadex. Anesth Prog. 2019 Fall;66(3):151-155. doi: 10.2344/anpr-66-01-07. PMID: 31545668; PMCID: PMC6759648. Go to original source... Go to PubMed...
    4. Mertes PM, Laxenaire MC. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol. 2002 Apr;19(4):240-62. doi: 10.1017/s0265021502000418. PMID: 12074414. Go to original source... Go to PubMed...
    5. Harper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery, and life­‑threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth. 2018 Jul;121(1):159-171. doi: 10.1016/j.bja.2018. 04. 014. Epub 2018 May 21. PMID: 29935567. Go to original source...
    6. Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol. 2017 Aug;140(2):335-348. doi: 10.1016/j.jaci.2017. 06. 003. PMID: 28780941; PMCID: PMC5657389. Go to original source...
    7. Adamus M, Cvachovec K, Černý V, Herold I, Horáček M, Průcha M, et al. Doporučený postup pro léčbu anafylaktické nebo anafylaktoidní reakce v průběhu anesteziologické péče. Anest intenziv Med. 2013;24(4):288-291.
    8. Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy. 2011 Jul;41(7):923-38. doi: 10.1111/j.1365-2222.2011.03779.x. PMID: 21668816. Go to original source... Go to PubMed...
    9. Ring J, Behrendt H, de Weck A. History and classification of anaphylaxis. Chem Immunol Allergy. 2010;95:1-11. doi: 10.1159/000315934. Epub 2010 Jun 1. PMID: 20519878. Go to original source... Go to PubMed...
    10. Schaller SJ, Fink H. Sugammadex as a reversal agent for neuromuscular block: an evidence­‑based review. Core Evid. 2013;8:57-67. doi: 10.2147/CE.S35675. Epub 2013 Sep 25. PMID: 24098155; PMCID: PMC3789633. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.